Jamieson Wellness Inc. (JWEL) Earnings Call Transcript & Summary

May 18, 2023

Toronto Stock Exchange CA Consumer Staples Personal Care Products shareholder_meeting 41 min

Earnings Call Speaker Segments

Operator

operator
#1

Good afternoon, everyone, and welcome to the 2023 Annual and Special Meeting of Shareholders of Jamieson Wellness, Inc. Please note that today's meeting is being recorded. On the call today from the Jamieson Wellness Board of Directors and management team are: Tim Penner, Chair of the Board; Michael Pilato, President and Chief Executive Officer; and Chris Snowden, Chief Financial Officer and Corporate Security. Before I turn the call over to Mr. Penner, please note that the presentation, which will follow the formal portion of the meeting, contains forward-looking statements and additional forward-looking statements may be made in response to your questions during the Q&A portion of the meeting. These statements reflect the company's current expectations regarding future events. Forward-looking statements are based on a number of assumptions and are subject to a number of risks and uncertainties, many of which are beyond the company's control that could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to, the factors discussed in Jamieson's filings with the Canadian Securities Administrators. These statements do not guarantee future performance and therefore, undue reliance should not be placed upon them. The company does not undertake any obligation to update the forward-looking statements made during this meeting, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. Finally, we would like to remind listeners that the company may refer to certain non-IFRS and other financial measures during this audio webcast. For further details on non-IFRS and other financial measures, including relevant definitions and certain reconciliations, see Jamieson's filings with the Canadian Securities Administrators. Also, please note that unless otherwise stated, all figures discussed today are in Canadian dollars and are occasionally rounded to the nearest million. [Operator Instructions] It is now my pleasure to turn today's meeting over to Tim Penner, Chair of the Board. The floor is yours.

Timothy Penner

executive
#2

Good afternoon. My name is Tim Penner, Chair of the Board of Directors and I would like to welcome you to this Annual and Special Meeting of the holders of common shares of Jamieson Wellness Inc., which I will refer to today as Jamieson. For those of you who are shareholders, thank you for joining us today. We also welcome all other guests in attendance. I have with me today Michael Pilato, our President and Chief Executive Officer; and Chris Snowden, Chief Financial Officer and Corporate Secretary of Jamieson. We are pleased to be able to meet in person with our shareholders again after 3 years of virtual meetings. Jamieson has been carefully monitoring COVID-19 pandemic and the associated public health restrictions, and we decided to hold this meeting in a hybrid format. This will allow shareholders the option to participate in the meeting virtually if they desire. The health and safety of our communities, shareholders, employees and other stakeholders is of paramount importance to us. And our main objective in hosting a hybrid meeting is to ensure that all shareholders have the same opportunities to participate and vote regardless of their geographic location or the particular constraints, circumstances or risks that they may be facing. The purpose of this meeting is as follows: one, to receive Jamieson's financial statements for the year ended December 31, 2022, and the auditor's report thereon; two, to reappoint Ernst & Young LLP as the auditors for Jamieson for the ensuing year and authorize the directors to fix their remuneration; three, to elect the Board of Directors of Jamieson for the ensuing year; four, to consider and, if deemed advisable, approve, with or without variation, an ordinary resolution approving, ratifying and confirming the adoption of Jamieson's fourth amended and restated long-term incentive plan and the unallocated options, rights or other entitlements thereunder; five, to consider and, if deemed advisable, approve with or without variation, an ordinary resolution approving, ratifying and confirming the unallocated options, rights or other entitlements under Jamieson's employee share purchase plan; and six, to consider and if deemed advisable, approve an advisory resolution on Jamieson's approach to executive compensation. These matters are set out in the company's Management Information Circular made available to shareholders in connection with this meeting. Jamieson elected to send out proxy-related materials for this meeting to shareholders using the notice and access provisions under National Instrument 51-102, Continuous disclosure obligations and National Instrument 54-101, Communications with beneficial owners of securities of a reporting issuer. I will refer to these provisions in this meeting as notice and access provisions. After the formal part of the meeting, Mike will be making some remarks, and we will follow that with a question period should you wish to ask any questions of him. As this meeting is a hybrid meeting held in part virtually via live webcast, we think it's necessary to set out a few rules applicable to those joining us virtually for the orderly conduct of business. One, questions can be submitted using the instant messaging service of the virtual interface. Please note that only registered shareholders or duly appointed proxyholders are entitled to submit questions in respect of a motion during the formal part of the meeting. Two, when asking a question, please indicate your name, which entity you represent, if any, and confirm whether you are a registered shareholder or a duly appointed proxyholder. For each question we answer, we will summarize the question and read out loud the name of the person who asked such question, and if applicable, the entity such person represents. Number three, questions may be submitted during the formal part of the meeting but will only be addressed during the question period at the end of the meeting. However, questions regarding procedural matters or directly related to motions before the meeting may be addressed during the meeting. Number four, for the purposes of those joining the meeting today virtually, voting on all matters will be conducted by electronic ballot. The online voting is open for all resolutions at this time. Registered shareholders and duly appointed proxyholders will be asked to vote on each item of business. If you are a beneficial owner of common shares and have not appointed yourself as a proxyholder and are, therefore, attending this meeting as a guest, you will not be entitled to vote. And number five, when you vote online, you will receive a message on the virtual interface requesting you to register your votes. You will only be permitted to vote while the polls are open. If you use your control number to log into the meeting, any vote you cast at the meeting will revoke any proxy you previously submitted. If you do not wish to revoke a previously submitted proxy, you should not vote at the meeting. There will also be opportunities during the meeting for a shareholder or proxyholder present with us in person to address the meeting. In that event, I would ask the shareholder or proxyholder who wishes to address the meeting to identify themselves by name prior to addressing the meeting. For those registered and duly appointed proxyholders voting in person at today's meeting, the form of ballot includes each item of business being voted on by ballot. You will be provided with a few moments to complete your ballot when each item of business is considered. To complete your ballot, please print your name and sign where indicated. If you are a proxyholder, please indicate the name of the shareholder for whom you have been appointed proxy to vote and indicate in the appropriate boxes whether you are for, against or choose to withhold by placing an X in the appropriate places on the ballot. We will now proceed with the formal portion of today's meeting. I will act as Chair of the meeting; and Chris Snowden, Jamieson's Chief Financial Officer and Corporate Secretary, will act as Secretary. With the consent of the meeting, I appoint Computershare Investor Services Inc. through its representatives as scrutineer to compute the votes of any polls taken at this meeting and to report thereon to me as Chair. The Notice calling this meeting, the accompanying Management Information Circular dated March 23, 2023, the consolidated financial statements for the years ended December 31, 2022 and 2021 and auditor's report thereon and the form of proxy have been provided to each shareholder of Jamieson of record at the close of business on March 20, 2023, by mail or electronically in accordance with the notice and access provisions. And I have been advised by Computershare Investor Services Inc. and have been provided with an affidavit of mailing confirming that the Notice calling this meeting, together with a form of proxy were mailed to each shareholder of record at the close of business on April 10, 2023. With the consent of the meeting, reading of the Notice of the Meeting will be dispensed with. I therefore declare that proper notice of this meeting has been given. A quorum of shareholders is at least 2 holders of common shares present in person or by telephonic or electronic means and holding or representing by proxy not less than 25% of the votes entitled to be cast at the meeting. I have received the preliminary report on attendance from the scrutineer and have determined that a quorum is present. I adopt this report and as notice has been served in accordance with the Ontario Business Corporations Act and the bylaws, I declare this meeting to be regularly called and properly constituted for the transaction of business. On behalf of the Board, I thank those shareholders who have chosen to attend the meeting in person and virtually today. I also thank those who submitted their proxies in advance. In order to have the meeting proceed efficiently, certain individuals have been asked to move and second the motions, which are to be called for the Notice of the Meeting. This is not intended to limit in any way your right to participate in the meeting. Shareholders who wish to make comments relating to the motion may do so after the motion has been seconded. The first item of business is to put before the meeting Jamieson's financial statements for the fiscal year ended December 31, 2022, and the auditor's report thereon. Those financial statements, together with the auditor's report thereon and forming part of the 2022 annual report, were made available to all shareholders of Jamieson by mail or electronically in accordance with the notice and access provisions. We would be pleased to receive any questions you may have regarding the financial statements during the question period later in this meeting. We will dispense with the reading of the financial statements and the auditor's report thereon. The next item of business is the appointment of auditors for the ensuing year and the authorization of the directors to fix their remuneration. May I have a motion, please?

Stephen Pirak

shareholder
#3

Mr. Chairman, my name is Stephen Pirak, and I'm a shareholder. I move that Ernst & Young LLP, chartered accountants, be reappointed auditors of Jamieson to hold office until the close of the next Annual Meeting of Shareholders or until their successors are appointed as such remuneration as may be fixed by the directors and the directors are authorized to fix such remuneration.

Julia Filice

shareholder
#4

My name is Julia Filice. I'm a shareholder. I second the motion.

Timothy Penner

executive
#5

You have heard the motion duly made and seconded. Unless there are any questions, I will move to the next item of business. The third item of business is the election of directors. Pursuant to Jamieson's articles, there can, at any time, be a minimum of 3 and a maximum of 10 directors of Jamieson. As described in the Management Information Circular made available to shareholders in connection with this meeting, there are 7 nominee directors for election as directors. The nominees are: Heather Allen; Lou Aronne; Tania Clarke, Michael Pilato; Timothy Penner; Catherine Potechin; Mei Ye. I will now nominate the directors. I nominate each of the persons whose name appears in the Management Information Circular, under the heading Election of Directors, to be a director of Jamieson until the close of the next Annual Meeting of Shareholders or until their successors are appointed. I am advised that each of the nominees is present -- is either present in person or has consented in writing to act as a director of Jamieson. It is now in order for someone to move and someone to second a resolution electing those nominated as directors of Jamieson.

Unknown Shareholder

shareholder
#6

Mr. Chairman, my name is [ Arusha Keel ] and I am a shareholder. I move that the persons who have been nominated for election as directors be elected as directors of Jamieson for the ensuing year or until their successors are elected or appointed.

Stephen Pirak

shareholder
#7

My name is Stephen Pirak, and I am a shareholder. I second the motion.

Timothy Penner

executive
#8

You've heard the motion duly made and seconded. As you know, Jamieson allows for the election of directors on an individual basis. According to our majority voting policy, any nominee who received a greater number of votes withheld than votes for cast with respect to his or her election by the shareholders is an uncontested election of -- in an uncontested election of directors, will tender his or her resignation promptly to the Governance Compensation and Nominating Committee, which will recommend to the Board whether or not to accept such resignation. I should advise the meeting that by virtue of votes already received by proxy, it is clear that all directors will receive more than enough votes to be elected today. I would like to advise the meeting that Jamieson did not receive any further nominations in accordance with its bylaws. I declare the nominations closed. I declare this motion to be carried and Heather Allen; Lou Aronne; Tania Clarke; Michael Pilato; Tim Penner; Catherine Potechin; Mei Ye, to have been elected as directors of Jamieson for the ensuing year or until their successors are elected or appointed. The next item of business is to consider, and if deemed advisable, to approve, with or without variation, an ordinary resolution approving, ratifying and confirming the adoption of Jamieson's fourth amended and restated long-term incentive plan and the unallocated options, rights or other entitlements thereunder. Please note that the company's third amended and restated long-term incentive plan was filed on SEDAR and appended to the Management Information Circular dated March 23, 2023. Having considered a recommendation made by institutional shareholder services, following the date of the Management Information Circular, the Board of Directors of Jamieson approved an amendment to the third amended and restated long-term incentive plan. The amendment decreases the maximum number of shares that may be subject to awards under Jamieson's fourth amended and restated long-term incentive plan and legacy option plan from 8.9% to 8.7% of the issued shares outstanding from time to time. The fourth amended and restated long-term incentive plan has been conditionally approved by the Toronto Stock Exchange. Pursuant to the policies of the Toronto Stock Exchange, the unallocated options, rights or other entitlements under a security-based compensation arrangement, such as the fourth amended and restated long-term incentive plan, must be approved every 3 years. The full text of the amended and restated LTIP resolution is set out in Schedule A to the Management Information Circular. May I have a motion, please?

Julia Filice

shareholder
#9

Mr. Chairman, my name is Julia Filice, and I'm a shareholder. I move that the amended and restated LTIP resolution set out in the Schedule A to Jamieson's Management Information Circular dated March 23, 2023, with respect to the fourth amended and restated long-term incentive plan be approved.

Unknown Shareholder

shareholder
#10

My name is [ Arusha Keel ] and I am a shareholder. I second the motion.

Timothy Penner

executive
#11

You have heard the motion duly made and seconded. Unless there are any questions, I will move to the next item of business. The next item of business is to consider, with or without variation, an ordinary resolution approving, ratifying and confirming the unallocated options, rights or other entitlements under Jamieson's employee share purchase plan. Pursuant to the policies of the Toronto Stock Exchange, the unallocated options, rights or other entitlements under a security-based compensation arrangement, such as the employee share purchase plan, must be approved every 3 years. The full text of the amended and restated employee share purchase plan resolution is set out in Schedule B of the Management Information Circular. May I have a motion, please?

Stephen Pirak

shareholder
#12

Mr. Chairman, my name is Stephen Pirak and I'm a shareholder. I move that the amended and restated employee share purchase plan resolution set out in Schedule B to Jamieson's Management Information Circular dated March 23, 2023, be approved.

Julia Filice

shareholder
#13

My name is Julia Filice and I am a shareholder. I second the motion.

Timothy Penner

executive
#14

You have heard the motion duly made and seconded. Unless there are any questions, I will move to the next item of business. The next item of business is to consider an advisory resolution approving Jamieson's approach to executive compensation as disclosed in the Management Information Circular under the heading Compensation of Executive Officers. Each year, the Board of Directors offers shareholders the opportunity to cast at each Annual General Shareholder meeting an advisory vote on Jamieson's approach to executive compensation. As this is an advisory vote, the Board will not be bound by the results of the vote. However, the Board will take the results of the vote into account, together with feedback received from shareholders when considering its approach to executive compensation in the future. May I have a motion, please?

Unknown Shareholder

shareholder
#15

Mr. Chairman, my name is [ Arusha Keel ] and I'm a shareholder. I move that the advisory say-on-pay resolution set out in Schedule C to Jamieson's Management Information circulated (sic) [ Circular dated ] March 23, 2023 be approved.

Stephen Pirak

shareholder
#16

My name is Stephen Pirak and I'm a shareholder. I second the motion.

Timothy Penner

executive
#17

Unless there are any questions, I will move on to the voting process. As I mentioned earlier, voting today will be conducted both in person and online. Voting on all resolutions will be by way of ballot: physical for those attending in person; and electronic for those attending virtually. The balloting is open to registered holders and appointed proxyholders. For those attending in person who wish to cast their votes, please complete a ballot and submit it to the scrutineer. Copies of the ballot can be obtained from the scrutineer. For those attending online, please register your votes by accessing the voting page and selecting the for or withhold buttons next to the name of each proposed director and next to the resolution with respect to the reappointment of Ernst & Young LLP as Jamieson's auditors. Please select the for or against buttons with respect to the approval of the amended and restated LTIP resolution; next to the resolution with respect to the approval of the amended employee share purchase plan resolution; and next to the resolution with respect to the advisory vote on Jamieson's approach to executive compensation. If you have not already submitted your ballot in person or voted online, as applicable, please complete your ballot now. We will give you 1 more minute. Ruth Winker, Senior Director of Corporate Affairs; of Jamieson will confirm for us when the polls have closed. [Voting]

Ruth Winker

executive
#18

The polls are now closed.

Timothy Penner

executive
#19

I have been advised by the scrutineer that the ballots and proxies deposited for the meeting have now been voted and that each of the resolutions has been carried with the effect that: one, each of the 7 nominees has been elected as a director of Jamieson to serve until the next Annual Meeting of Shareholders or until their successors are elected or appointed; two, the appointment of Ernst & Young LLP as the auditors of Jamieson has been approved, and the Board of Directors has been authorized to fix their group remuneration; three, the amended and restated LTIP resolution has been approved; four, the amended employee share purchase plan resolution has been approved; and five, the advisory say-on-pay resolution has been approved. We will file a report setting out the voting results on the SEDAR website following this meeting. The formal items of business as set out in the Notice of Meeting have now been dealt with. If there's no further business, may I have a motion for the termination of the formal portion of the meeting?

Julia Filice

shareholder
#20

Mr. Chairman, my name is Julia Filice and I am a shareholder. I so move.

Unknown Shareholder

shareholder
#21

My name is [ Arusha Keel ] and I'm a shareholder. I second the motion.

Timothy Penner

executive
#22

I declare the motion to be carried. So this concludes the formal portion of today's meeting. I will now turn the meeting over to Mike Pilato for some remarks. Following his remarks, there will be a question-and-answer period. Mike?

Michael Pilato

executive
#23

Perfect. Thank you, Tim. Welcome, everyone. Thanks for joining us today and for your support. I'm going to walk through a few slides, just give an update on 2022 and our strategy and some of our strategic initiatives, and then we'll move on to questions. First off, I do want to remind everyone that some of the numbers we're talking about and some of the stuff we're talking about today are forward-looking statements and non-IFRS financial measures as indicated at the start of the meeting. We also at Jamieson, want to ensure that our Jamieson land acknowledgment is read here today, so I will read it briefly. Jamieson Wellness gratefully acknowledges that our workplace lies in the traditional territories of the First Nation, Inuit and Métis Nations. Through our dispersed team, Jamieson Wellness conducts its work on the traditional territories of several Indigenous peoples across the world. As part of our acknowledgment, we are committed to amplifying Indigenous voices and working in partnership with Indigenous organizations, community members and ambassadors on our mission to improve the world's health and wellness. With that, we'll jump into a few slides. 2022 was a very big year for Jamieson Wellness as we turned 100 years old. And with that, brought a couple of big occasions for us: one, an opportunity to celebrate inside the company, you can see a picture there on the left, of which we celebrated 100th anniversary of our company, which is not something that happens regularly or every day in companies. But more importantly, we were able to take our celebration and turn that into an advertising campaign that we launched globally to celebrate our heritage and really talk to consumers about our great century of success, what that brings in terms of knowledge, expertise and what we've been able to bring to the consumer. And we did a global advertising and marketing campaign on that, that was quite successful, and we're quite proud of it. It also gave us the opportunity to pivot for really strategic thought in terms of what is our growth strategy for the next 100 years of global value creation. And as we've talked about in the past, we have 4 very clear growth markets that we're focused on. Number one is our home market of Canada where we are the clear market leader and continue to expand our leadership. We have focused on entry and expansion into the United States, the world's largest vitamin mineral supplement market. We have continued to grow and continue to invest in China, the world's second-largest vitamin mineral supplement market and our international business in another about 45 countries around the world. We're really focused there in a few ways. One, our people, our values and our culture, really focused on building a great culture within Jamieson made up of great professionals that really believe in what we're doing and really drive our business forward and represent our values and our company. We're built on operational excellence. We are some of the best manufacturers and managers of supply chain in the industry really globally out there against all of our peers, and it really does set us apart in the marketplace. We have really focused on developing ESG practices that continue to evolve and continue to get better year after year. We continue to focus on the consumer and the global health and wellness megatrend that has been behind the category for years prior to the pandemic, through the pandemic and will continue post-pandemic. And we, of course, always have the opportunity to continue to look for acquisition opportunities around the world to accelerate our growth. In Canada, in 2022, we saw consistent demand from our elevated consumer base, and we continue to expand our market leadership. We also continued to focus on world-class marketing around our 100-year anniversary and best-in-class innovation, where we most recently won 5 Best New Product Awards voted by consumers through BrandSpark, which we're quite proud of. In the U.S., we really started to establish our presence through our acquisition of Nutrawise and the youtheory brand. We acquired this brand in 2022, closed that deal on July 19, and have since been integrating it into Jamieson. It was really important to us in our strategy to scale this business that we had a brand that consumers demand in the U.S., in the world's largest consumer -- sorry, vitamin mineral health supplement market at $40 billion. And to put that in comparison, the Canadian market is about $2 billion. So it is a very big market with consumers almost doubling consumption per capita on vitamins compared to here in Canada. We established our presence in the U.S. through the acquisition. We purchased youtheory, a premium brand with premium products that line up to the quality standards of Jamieson. It is a mission-driven and culturally aligned organization to ours. With that acquisition, we've got our fourth state-of-the-art manufacturing facility in Irvine, California with 2-piece encapsulation really being the specialty of that manufacturing facility. They brought a diverse product distribution assortment of products and really, it's an opportunity for us to leverage our Jamieson portfolio under the youtheory brand, and we've started to launch a couple of our formulas from the Jamieson portfolio under the youtheory brand in 2023. We've identified many revenue growth opportunities and cost synergies, and we continue to work through that as we come up on our 1-year anniversary of the acquisition in July. In China, we continue to capitalize on our experience in China. We've been there for years. We've really started to grow that business. And the growth in China really continues to -- our growth continues to outpace the average. We decided to go direct in China in 2022, and we announced the acquisition of our distributor assets. We were a distributor-led business in China up until now. We now control the entire value chain in China. We now have direct relationships with our customers in China and our consumers in China and really see this as an opportunity to accelerate our growth in China. We subsequently have also announced our third-party partnership with DCP Capital. That closed this week. And now have some real expertise partnered with the team that we have built on the ground in China, driving our business forward in that country. As a reminder, China is the second-largest vitamin mineral supplement market in the world at $30 billion. We also continue to amplify our international presence in markets outside of Canada, the United States and China. We've had growth in key geographies of the Middle East and Southeast Asia through 2022, and we entered new markets such as Mexico and Croatia. We've onboarded new distribution partners in Spain and Italy, which are also quite sizable vitamin mineral supplement markets, and we feel that we -- our new distribution partners are set up to take advantage of those opportunities. We launched 5 new products in the European club channel and we secured our first official club listing in Australia and now have a product in the Australian market. This slide here really just shows our consistent history of organic growth. This is not a story of growth for a few years. This goes back decades, and it really is driven by what I talked about earlier. The consumer tailwinds behind health and wellness, combined with operational excellence, marketing excellence, our ability to innovate and our ability to expand around the world. And if you just take a step back about 9 years ago to when this company was first purchased by a private equity firm, the revenue was pacing just under $200 million. As we went public in 2017, our revenue was $300 million and as we guided for 2023, we're guiding between $670 million and $700 million of revenue, really through organic growth here in Canada, expansion internationally and organic growth in China and some acquisitions we've made along this journey. Our 2022 financial results, we were quite pleased with and were quite impressive with 21.4% growth in revenue and 23.6% of adjusted EBITDA growth. We also grew adjusted net earnings and adjusted diluted earnings per share at 18% and 17.4%, respectively. When it comes to ESG, we have really grounded our ESG Impact Strategy in internationally recognized standards and have really started to focus on that as an organization and a key strategy for us. We have broad perspectives and deep awareness throughout the organization. From the environmental perspective, we're building a strong framework for a greener planet, and we made public commitments of 50% reduction in Scope 1 and 2 emissions by 2030. And we committed to developing a formal action plan to reach net 0 by 2050. That's going to take some work. It's going to take some planning, and we want to do that work before we formally make that commitment, but the work is in progress. We've also started by building out some partnerships, EcoVadis, a sustainability ratings partner that is helping us in our third-party sustainable policy and practice. We signed a partnership with the Ellen MacArthur Foundation, the Essex Regional Conservation (sic) [ Essex Region Conservation ] area and a partnership with the Caldwell First Nations in the Essex County to really help them with some forestation projects in the area of which this company was founded in which most of our manufacturing facilities currently sit. From a social perspective, a couple or 3 years ago, we put out very clear 2025 diversity, equity and inclusion targets, which you can see on the right there. And we are focused on hitting those targets. We've made a tremendous amount of progress in our organization. We have annual targets that are built into our leadership's short-term incentive plans, and we continue to evolve and improve our company around diversity, equity and inclusion. When it comes to training, we have annual training of which we've reached in the high 90 percentage of employees participating. From fair representation in leadership, we are committed to all leadership and Board roles held by 50% of women and 25% of racialized persons. We have achieved that target at the Board level, and we are on pace to achieve that target at the leadership -- management leadership level. And from a new hire representation perspective, we want to make sure that as we bring new employees in, we are best representing the world around us, and we have maintained and continued to deliver on our targets in that perspective. From a governance perspective, we established more ethical operations and sustainable practices. We signed with the United Nations Global Compact. When it comes to The Globe and Mail and the Board Games scores that they publish every year, we move significantly up the ratings year-over-year as we've made vast improvements in our governance structure, and we are reporting and planning to report under TCFD into the future. As we jump out of 2022 and all the great work we did, we just want to stop a little bit and talk about 2023. We are off to a phenomenal start in 2023. We reported our first quarter earnings a couple of weeks ago with 32% consolidated revenue growth, 30% at the branded revenue level. We grew adjusted EBITDA $3.6 million, which was 17% and adjusted diluting -- diluted earnings per share came in at $0.21. As noted in our 2023 guidance, we are investing some SG&A ahead of growth in both China and the United States to ensure that those platforms are built for the future. We have the right infrastructure, the right marketing dollars, the right brand building dollars to really accelerate growth in the top line of those countries for the foreseeable future. We made great progress in our pillars so far in 2023. In Canada, increasing momentum from the elevated consumer base, we continue to see strong consumption in Q1 and consumption outpaced our shipments in the quarter as the Canadian consumer continues to show resilience and a true engagement in the category post-COVID. We've -- we're launching many new innovations. And in Q1, we launched 2 new gummy products to meet the growing demand of consumers on the fastest-growing format of vitamins, which is gummies today. In the U.S., we over-delivered our revenue expectations, really driven again by over delivery of consumption expectations. We had the U.S. consumer, again, also showed great resilience in Q1. And we began production on many key innovations for the back half -- for Q2 and the back half of the year, including a new and improved turmeric product that we're quite proud to get to market in Q2. In China, we closed our distributor asset purchase -- acquisition purchase. We closed our DCP partnership just about 48 hours ago, and we officially opened our new Shanghai office and now have 32 team members on the ground in Shanghai, employed by Jamieson running this business day in and day out with full ownership of the value chain. And from an international perspective, we came out of 2022 with some slowing business in Eastern Europe around the geopolitical issues going on in the Ukraine and Russia. We have no business in the Ukraine or Russia, but the business in the surrounding or neighboring countries where we saw an impact from just hyperinflation from the war. We have seen those declines slow in the front part of this year and see some good indicators of consumer resilience coming out of lapping that full year impact of that. And we see increasing strength in the Middle East, which is a region of focus for us. With that, I'm going to turn it back over to Tim, and we can open the floor for questions.

Timothy Penner

executive
#24

Thanks, Mike. I would like to now open the floor for questions. And as I do that, I ask that all online attendees who would like to ask a question, use the instant messaging feature of the virtual interface to do so. We'll ask -- we will answer as many questions as time permits. We will now give online attendees a moment to type in their questions. For each question we answer from online attendees, we will summarize the question, read out loud the name of the person who asked that question and, if applicable, the entity such person represents. Questions which were already answered or that are redundant or repetitive will not be answered. Okay. Ruth?

Ruth Winker

executive
#25

There are no questions online at this time, but I see we have a question here in person.

Timothy Penner

executive
#26

One in the room.

Unknown Attendee

attendee
#27

I'm [ Paul Durnan ] from Burlington. Talk about China. Now am I right in saying it's a joint venture? You have a percent of the manufacturing and total sales of that 1 factory? Is that the way it goes? You've got -- you don't have full ownership of all of your China operations. Is that right?

Michael Pilato

executive
#28

So we have a joint venture in China on the commercial side of the business, which would be any sales in China. So it's a 66% -- 2/3 owned Jamieson, 1/3 owned joint venture with our partner, DCP Capital. Our manufacturing facilities, though, are all in Canada. We 100% own the manufacturing facilities and everything to do with manufacturing in terms of selling products or getting products over to China. So really, it's the commercial aspect of the business in China, where through transfer pricing, we sell products to the China joint venture, and then they would sell that out into the Chinese marketplace.

Unknown Attendee

attendee
#29

Okay. The DCP joint venture, what's behind that set of initials? Is it government controlled? Or is it -- who owns that? Or...

Michael Pilato

executive
#30

Yes. So you want to talk about that one, Chris.

Christopher Snowden

executive
#31

DCP is an international private equity fund of money primarily raised in Hong Kong and in Southeast Asia and in China.

Timothy Penner

executive
#32

Other questions? Ruth, do you have any online now?

Ruth Winker

executive
#33

There's no questions online.

Timothy Penner

executive
#34

Any other questions in the room? Okay. If there are no other questions, we would like to thank you for attending today and for your continued support of Jamieson.

Operator

operator
#35

This concludes the meeting. You may now disconnect.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Jamieson Wellness Inc. transcript — plus 250,000+ transcripts from 12,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to Jamieson Wellness Inc. earnings transcripts and 250,000+ others is available through the EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.